Dopaminergic drug treatment remediates exaggerated cingulate prediction error responses in obsessive-compulsive disorder

[1]  Ninon Burgos,et al.  New advances in the Clinica software platform for clinical neuroimaging studies , 2019 .

[2]  T. Robbins,et al.  D2 receptors and cognitive flexibility in marmosets: tri-phasic dose–response effects of intra-striatal quinpirole on serial reversal performance , 2018, Neuropsychopharmacology.

[3]  Peter B. Jones,et al.  Abnormal reward prediction error signalling in antipsychotic naïve individuals with first episode psychosis or clinical risk for psychosis , 2017, bioRxiv.

[4]  M. Bloch,et al.  Obsessive-Compulsive Disorder: Advances in Diagnosis and Treatment , 2017, JAMA.

[5]  T. Robbins,et al.  A trans-diagnostic perspective on obsessive-compulsive disorder , 2017, Psychological Medicine.

[6]  Valerie Voon,et al.  Distinct cortico-striatal connections with subthalamic nucleus underlie facets of compulsivity , 2017, Cortex.

[7]  R. Dolan,et al.  Increased fronto-striatal reward prediction errors moderate decision making in obsessive–compulsive disorder , 2017, Psychological Medicine.

[8]  J. Narayanaswamy,et al.  Clinical practice guidelines for Obsessive-Compulsive Disorder , 2017, Indian journal of psychiatry.

[9]  I. Engelhard,et al.  Perseveration induces dissociative uncertainty in obsessive-compulsive disorder. , 2016, Journal of behavior therapy and experimental psychiatry.

[10]  Penny A. MacDonald,et al.  Pramipexole Impairs Stimulus-Response Learning in Healthy Young Adults , 2016, Front. Neurosci..

[11]  D. Yuce,et al.  A Promising Preliminary Study of Aripiprazole for Treatment-Resistant Childhood Obsessive-Compulsive Disorder. , 2015, Journal of child and adolescent psychopharmacology.

[12]  S. Kasper,et al.  Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials , 2013, The international journal of neuropsychopharmacology.

[13]  C. P. Ford.  The role of D2-autoreceptors in regulating dopamine neuron activity and transmission , 2014, Neuroscience.

[14]  J. Hodsoll,et al.  Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis , 2014, BMC Psychiatry.

[15]  T. Robbins,et al.  Goal-directed learning and obsessive–compulsive disorder , 2014, Philosophical Transactions of the Royal Society B: Biological Sciences.

[16]  T. Robbins,et al.  Role of Dopamine D2 Receptors in Human Reinforcement Learning , 2014, Neuropsychopharmacology.

[17]  T. Robbins,et al.  Methamphetamine-induced disruption of frontostriatal reward learning signals: relation to psychotic symptoms. , 2013, The American journal of psychiatry.

[18]  Anthony A Grace,et al.  Evaluation of animal models of obsessive-compulsive disorder: correlation with phasic dopamine neuron activity. , 2013, The international journal of neuropsychopharmacology.

[19]  Mehdi Sayyah,et al.  EFFECTS OF ARIPIPRAZOLE AUGMENTATION IN TREATMENT‐RESISTANT OBSESSIVE‐COMPULSIVE DISORDER (A DOUBLE BLIND CLINICAL TRIAL) , 2012, Depression and anxiety.

[20]  Steven C. R. Williams,et al.  Methylphenidate Effects on Prefrontal Functioning During Attentional-Capture and Response Inhibition , 2012, Biological Psychiatry.

[21]  T. Robbins,et al.  Punishment promotes response control deficits in obsessive-compulsive disorder: evidence from a motivational go/no-go task , 2012, Psychological Medicine.

[22]  Szabolcs Kéri,et al.  The Effect of Dopamine Agonists on Adaptive and Aberrant Salience in Parkinson's Disease , 2012, Neuropsychopharmacology.

[23]  Pradeep J Nathan,et al.  Neurochemical Enhancement of Conscious Error Awareness , 2012, The Journal of Neuroscience.

[24]  D. Mathalon,et al.  Error-related negativity in individuals with obsessive–compulsive symptoms: Toward an understanding of hoarding behaviors , 2012, Biological Psychology.

[25]  T. Robbins,et al.  Response Perseveration in Stimulant Dependence Is Associated with Striatal Dysfunction and Can Be Ameliorated by a D2/3 Receptor Agonist , 2011, Biological Psychiatry.

[26]  H. Westenberg,et al.  Dysfunctional Reward Circuitry in Obsessive-Compulsive Disorder , 2011, Biological Psychiatry.

[27]  E. Spina,et al.  Effect of Aripiprazole Augmentation of Serotonin Reuptake Inhibitors or Clomipramine in Treatment-Resistant Obsessive-Compulsive Disorder: A Double-Blind, Placebo-Controlled Study , 2011, Journal of clinical psychopharmacology.

[28]  James L. Abelson,et al.  Hyperactive Error Responses and Altered Connectivity in Ventromedial and Frontoinsular Cortices in Obsessive-Compulsive Disorder , 2011, Biological Psychiatry.

[29]  M. Ullsperger,et al.  Dopamine-Mediated Reinforcement Learning Signals in the Striatum and Ventromedial Prefrontal Cortex Underlie Value-Based Choices , 2011, The Journal of Neuroscience.

[30]  H. Westenberg,et al.  Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive-compulsive disorder. , 2010, Archives of general psychiatry.

[31]  Trevor R. Norman,et al.  Dopamine D1 receptor binding in the anterior cingulate cortex of patients with obsessive–compulsive disorder , 2010, Psychiatry Research: Neuroimaging.

[32]  J. Bostwick,et al.  Impact of dopamine agonists on compulsive behaviors: a case series of pramipexole-induced pathological gambling. , 2010, Psychosomatics.

[33]  Angie A. Kehagia,et al.  Learning and cognitive flexibility: frontostriatal function and monoaminergic modulation , 2010, Current Opinion in Neurobiology.

[34]  P. Fletcher,et al.  The Neural Underpinnings of Associative Learning in Health and Psychosis: How Can Performance Be Preserved When Brain Responses Are Abnormal? , 2010, Schizophrenia bulletin.

[35]  L. Koran,et al.  Double-blind study of dextroamphetamine versus caffeine augmentation for treatment-resistant obsessive-compulsive disorder. , 2009, The Journal of clinical psychiatry.

[36]  T. Münte,et al.  Brain Potentials of Conflict and Error-Likelihood Following Errorful and Errorless Learning in Obsessive-Compulsive Disorder , 2009, PloS one.

[37]  Trevor R. Norman,et al.  Dopamine D1 receptor binding in the striatum of patients with obsessive-compulsive disorder. , 2009, Journal of affective disorders.

[38]  J. A. Boer,et al.  Patients with obsessive–compulsive disorder are impaired in associative learning based on external feedback , 2009, Psychological Medicine.

[39]  Alessandra Gorini,et al.  In vivo PET study of 5HT2A serotonin and D2 dopamine dysfunction in drug-naive obsessive-compulsive disorder , 2008, NeuroImage.

[40]  R. Constantinescu.  Update on the use of pramipexole in the treatment of Parkinson’s disease , 2008, Neuropsychiatric disease and treatment.

[41]  E T Bullmore,et al.  Substantia nigra/ventral tegmental reward prediction error disruption in psychosis , 2008, Molecular Psychiatry.

[42]  E. Gershon,et al.  Genome-wide association in bipolar , 2008, Molecular Psychiatry.

[43]  Petra E. Pajtas,et al.  Single dose of a dopamine agonist impairs reinforcement learning in humans: Behavioral evidence from a laboratory-based measure of reward responsiveness , 2008, Psychopharmacology.

[44]  D. Perani,et al.  Fluvoxamine Treatment and D2 Receptors: a Pet Study on OCD Drug-Naïve Patients , 2007, Neuropsychopharmacology.

[45]  B. Abler,et al.  Human reward system activation is modulated by a single dose of olanzapine in healthy subjects in an event-related, double-blind, placebo-controlled fMRI study , 2007, Psychopharmacology.

[46]  R. Dolan,et al.  Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans , 2006, Nature.

[47]  Henrik Walter,et al.  Prediction error as a linear function of reward probability is coded in human nucleus accumbens , 2006, NeuroImage.

[48]  R. Poldrack,et al.  Ventral–striatal/nucleus–accumbens sensitivity to prediction errors during classification learning , 2006, Human brain mapping.

[49]  Thomas Villmann,et al.  Serotonin and dopamine transporter imaging in patients with obsessive–compulsive disorder , 2005, Psychiatry Research: Neuroimaging.

[50]  Mark W. Woolrich,et al.  Advances in functional and structural MR image analysis and implementation as FSL , 2004, NeuroImage.

[51]  Michael J. Frank,et al.  By Carrot or by Stick: Cognitive Reinforcement Learning in Parkinsonism , 2004, Science.

[52]  N. V. D. Van der Wee,et al.  Enhanced dopamine transporter density in psychotropic-naive patients with obsessive-compulsive disorder shown by [123I]{beta}-CIT SPECT. , 2004, The American journal of psychiatry.

[53]  H. Westenberg,et al.  Low level of dopaminergic D2 receptor binding in obsessive-compulsive disorder , 2004, Biological Psychiatry.

[54]  Karl J. Friston,et al.  Dissociable Roles of Ventral and Dorsal Striatum in Instrumental Conditioning , 2004, Science.

[55]  T. Insel,et al.  D-Amphetamine in obsessive-compulsive disorder , 2004, Psychopharmacology.

[56]  Cameron S. Carter,et al.  Overactive Action Monitoring in Obsessive-Compulsive Disorder , 2003, Psychological science.

[57]  P. Montague,et al.  Activity in human ventral striatum locked to errors of reward prediction , 2002, Nature Neuroscience.

[58]  P. Rosenzweig,et al.  A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers , 2002, Human psychopharmacology.

[59]  A. Dickinson,et al.  Neuronal coding of prediction errors. , 2000, Annual review of neuroscience.

[60]  W. Miller,et al.  The self-regulation questionnaire. , 1999 .

[61]  C. Wright,et al.  Steady‐State Pharmacokinetic Properties of Pramipexole in Healthy Volunteers , 1997, Journal of clinical pharmacology.

[62]  Peter Dayan,et al.  A Neural Substrate of Prediction and Reward , 1997, Science.

[63]  D J Sanger,et al.  Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity. , 1997, The Journal of pharmacology and experimental therapeutics.

[64]  P. Benfield,et al.  A Review of its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Efficacy in the Management of Schizophrenia , 1996 .

[65]  Acute Psychostimulant Challenge in Primary Obsessive‐Compulsive Disorder , 1991, Journal of clinical psychopharmacology.

[66]  W. Goodman,et al.  The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. , 1989, Archives of general psychiatry.

[67]  D. C. Howell.  Statistical Methods for Psychology , 1987 .

[68]  Pete R. A. Keller,et al.  Innovations in Clinical Practice: A Source Book. , 1985 .

[69]  A. Grace,et al.  Intracellular and extracellular electrophysiology of nigral dopaminergic neurons—1. Identification and characterization , 1983, Neuroscience.

[70]  A. Bond,et al.  The use of analogue scales in rating subjective feelings , 1974 .